SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,208.53 -573.23
( -0.77%)

Global Indices

Nasdaq

52,442.46 -151.83
(-0.29%)

Dow Jones

7,640.91 -37.07
(-0.48%)

Hang Seng

63,634.18 141.19
(0.22%)

Nikkei 225

10,692.77 42.33
(0.40%)

Forex

USD-INR

95.47 0.03
(0.03%)

EUR-INR

110.72 -0.23
(-0.20%)

GBP-INR

129.12 -0.04
(-0.03%)

JPY-INR

0.62 0.00
(0.29%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524715

INE044A01036

93.2373503

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNPHARMA

138.81

441957.5

EPS(TTM)

Face Value()

Div & Yield %

13.27

0.87

Back

Sun Pharmaceuticals Industries Ltd

Sun Pharmaceutical Industries consolidated net profit rises 27.04% in the June 2026 quarter

Jul 31,2026

Net profit of Sun Pharmaceutical Industries rose 27.04% to Rs 2894.79 crore in the quarter ended June 2026 as against Rs 2278.63 crore during the previous quarter ended June 2025. Sales rose 10.14% to Rs 15183.55 crore in the quarter ended June 2026 as against Rs 13786.07 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	15183.55	13786.07	10
OPM %	29.10	31.20	-
PBDT	5041.62	4691.32	7
PBT	4302.90	3990.77	8
NP	2894.79	2278.63	27

74,208.53 -573.23 ( -0.77%)

52,442.46 -151.83 (-0.29%)

7,640.91 -37.07 (-0.48%)

63,634.18 141.19 (0.22%)

10,692.77 42.33 (0.40%)

95.47 0.03 (0.03%)

110.72 -0.23 (-0.20%)

129.12 -0.04 (-0.03%)

0.62 0.00 (0.29%)